In patients with HSD17B13 variants, the HCC incidence was significantly reduced in alcohol‐related FLD (HSD17B13 variants, OR = 0.29, 95% CI = 0.10–0.85, p = 0.02, Figure 2A). This evidence concerns the gene HSD17B13 and hepatocellular carcinoma.